Hypoalbuminemia as a risk factor for over-anticoagulation

American Journal of Medicine

Volumn 112, Issue 3, 2002, Pages 247-248

  Tincani, Enrico ^a   Mazzali, Fausto ^a   Morini, Lorenzo ^a  

^a S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; WARFARIN;

ABSORPTION; AGED; ALBUMIN BLOOD LEVEL; ANTICOAGULATION; BIOLOGICAL MONITORING; BLOOD SAMPLING; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; HUMAN; HYPOALBUMINEMIA; LETTER; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; STATISTICAL ANALYSIS; THROMBOEMBOLISM;

AGED; BLOOD COAGULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; LOGISTIC MODELS; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; VENOUS THROMBOSIS; WARFARIN;

EID: 0037082545     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(01)00957-3     Document Type: Letter

References (6)

1. Antithrombotic therapy for venous thromboembolic disease
2. Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy
3. A randomized trial comparing 5-mg an 10-mg warfarin loading doses
4. Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range
5. Flexible induction dose regimen for warfarin and prediction of maintenance dose
6. Management and dosing of warfarin therapy